Send us a text Imagine being told that what you thought were personal failings are actually symptoms of a misunderstood condition. Join me, Jeanette Graham, as I navigate the intricate world of ADHD and uncover the soaring diagnosis rates in the U.S., where adult diagnoses have skyrocketed to 15.5%. With expert insights from Dr. Patel, we probe into why these numbers are higher in the U.S., citing reduced stigma and advanced diagnostic tools as driving forces. We also discuss the hurdle many ...
All content for Excuse My ADHD is the property of Jeanette and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Send us a text Imagine being told that what you thought were personal failings are actually symptoms of a misunderstood condition. Join me, Jeanette Graham, as I navigate the intricate world of ADHD and uncover the soaring diagnosis rates in the U.S., where adult diagnoses have skyrocketed to 15.5%. With expert insights from Dr. Patel, we probe into why these numbers are higher in the U.S., citing reduced stigma and advanced diagnostic tools as driving forces. We also discuss the hurdle many ...
This is a doozy as in this episode ran close to 2 hours so this is part one. Listen in as we discuss some of the miscommunications that can happen when ADHD brain meets neurotypical brain. Of course we also go off on a few tangents what interview would be complete with out them? Russ is the Author of “Living With ADHD and CPTSD”. He was born in Edmonton Alberta Canada, someone who is learning to understand his disabilities “ADHD and CPTSD” and overcome them to live a h...
Excuse My ADHD
Send us a text Imagine being told that what you thought were personal failings are actually symptoms of a misunderstood condition. Join me, Jeanette Graham, as I navigate the intricate world of ADHD and uncover the soaring diagnosis rates in the U.S., where adult diagnoses have skyrocketed to 15.5%. With expert insights from Dr. Patel, we probe into why these numbers are higher in the U.S., citing reduced stigma and advanced diagnostic tools as driving forces. We also discuss the hurdle many ...